

No Conditional US Approval So Far For ImmuPharma Lupus Drug Lupuzor


UK TRADING UPDATE SUMMARY: Gore Street Energy Energises Drumkee


IN BRIEF: Immupharma Says L1 Capital Converts USD200,000 Of Security


(Sharecast News) - Specialist drug discovery and development company ImmuPharma updated the market on the new optimised international phase 3 trial of...


ImmuPharma Partner To Discuss Progression Of Lupuzor Drug With US FDA


UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter


UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise


IN BRIEF: Immupharma Raises Stake In Incanthera To 15.4%